BygraveF, BenedettiA.Calcium: its modulation in liver by cross-talk between the actions of the glucagon and calcium-mobilizing ago-nists. Biochem J1993;296:1–14.
2.
Robles-FloresM, AllendeG, PinaE, Garcia-SainzJA.Cross-talk between glucagon- and adenosine-mediated signalling systems in rat hepatocytes: effects on cyclic AMP-phosphodiesterase activity. Biochem J1995;312:763–7.
3.
BlacheP, KevranA, DufourM, MartinezJ, Le-NguyenD, LotersztajnS, PavoineC, PeckerF, BatailleD.Glucagon-9(19-29), a Ca++ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase. J Biol Chem1990;265:21514–9.
4.
BlacheP, KervranA, Le-NguyenD, DufourM, Cohen-SodalA, DuckworthW, BatailleD.Endopeptidase from rat liver membranes, which generates miniglucagon from glucagon. J Biol Chem1993;268:21748–53.
5.
WhiteMF, StegmannEW, DullTJ, UllrichA, KahnCR.Characterization of an endogenous substrate of the insulin receptor in cultured cells. J Biol Chem1987;262:9769–77.
6.
WildenPA, BackerJM, KahnCR, CahillDA, SchroederGJ, WhiteMF.The insulin receptor with phenylalanine replacing tyrosine-1146 provides evidence for separate signals regulating cellular metabolism and growth. Proc Nat Acad Sci USA1990;87:3358–62.
7.
ThiesRS, UllrichA, McClainDA.Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor. J Biol Chem1989;264:12820–5.
8.
GoldfineID.The insulin receptor: molecular biology and trans-membrane signalling. Endocr Rev1987;8:235.
9.
MyersM, GrammerT, WangL, SunX, BlenisJ, PierceJ, WhiteM.IRS-1-dependent and -independent pathways in insulin signalling. Diabetes1994;43:1A.
10.
O'BrienR, GrannerD.Regulation of gene expression by insulin. Biochem J1991;278:609–19.
11.
PershadsinghHA, GaleRD, McDonaldJM.Chelation of intra-cellular calcium prevents stimulation of glucose transport by insulin and insulinomimetic agents in the adipocyte. Evidence for a common mecha-nism. Endocrinology1987;121:1727–32.
12.
SolomonS, PalazzoloM, ElamM, GreenS, RaghowR.Regulation of calmodulin gene expression by insulin is both transcrip-tional and post-transcriptional. J Lab Clin Med1994;124:348–58.
13.
SacksDB, Fujita-YamaguchiY, GaleRD, McDonaldJM.Tyrosine-specific phosphorylation of calmodulin by the insulin receptor kinase purified from human placenta. Biochem J1989;263:803–12.
DuckworthWC.Increasing understanding of calmodulin-insulin interactions, [editorial]. J Lab Clin Med1994;124:311–2.
16.
SacksDB, DavisHW, CrimminsDL, McDonaldJM.Insulin-stimulated phosphorylation of calmodulin. Biochem J1992;286:211–6.
17.
DuckworthWC.Insulin degradation: mechanisms, products, and significance. Endocr Rev1988;9:319–45.
18.
BackerJM, KahnCR, WhiteMF.The dissociation and degrada-tion of internalized insulin occur in the endosomes of rat hepatoma cells. J Biol Chem1990;265:14828–35.
19.
HamelFG, MahoneyMJ, DuckworthWC.Degradation of intraendosomal insulin by insulin-degrading enzyme without acidifica-tion. Diabetes1991;40:436–43.
20.
YonezawaK, YokonoK, ShiiK, HariJ, YasoS, AmanoK, SakamotoT, KawaseY, AkiyamaH, NagataM, BabaS.Insulin-degrad-ing enzyme is capable of degrading receptor-bound insulin. Biochem Biophys Res Commun1988;150:605–14.
21.
DuckworthWC, HamelFG, LiepnieksJJ, PeavyDE, RyanMP, HermodsonMA, FrankBH.Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytes. Biochem Biophys Res Commun1987;147:615–21.
22.
DuckworthWC, HamelFG, PeavyDE, LiepnieksJJ, RuanMP, HermodsonMA, FrankBH.Degradation products of insulin generated by hepatocytes and by insulin protease. J Biol Chem1988;263:1826–33.
23.
HamelFG, PosnerBI, BergeronJJM, FrankBH, DuckworthWC.Isolation of insulin degradation products from endosomes derived from intact rat liver. J Biol Chem1988;263:6703–8.
24.
BeckerAB, RothRA.An unusual active site identified in a fami-ly of zinc metalloendopeptidases. Proc Natl Acad Sci USA1992;89:3835–9.
25.
RawlingsND, BarrettAJ.Homologues of insulinase, a new superfamily of metalloendopeptidases. Biochem J1991;275:389–91.
26.
ShiiK, RothRA.Inhibition of insulin degradation by hepatoma cells after microinjections of monoclonal antibodies to a specific cytoso-lic protease. Proc Natl Acad Sci USA1986;83:4147.
27.
AuthierF, RachubinskiR, PosnerB, BergeronJ.Endosomal pro-teolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. J Biol Chem1994;269:3010–6.
28.
SteinerDF.Insulin today. Diabetes1977;26:322–31.
29.
DrazninB, TrowbridgeM.Inhibition of intracellular proteolysis by insulin in isolated rat hepatocytes: possible role of internalized hor-mone. J Biol Chem1982;257(20):11988–93.
30.
PeavyDE, EdmondsonJW, DuckworthWC.Selective effects of inhibitors of hormone processing on insulin action in isolated hepato-cytes. Endocrinology1984;114:753–60.
31.
HamelFG, PeavyDE, RyanMP, DuckworthWC.High perfor-mance liquid chromatographic analysis of insulin degradation products from isolated hepatocytes: effects of inhibitors suggest intracellular and extracellular pathways. Diabetes1987;36:702–8.
32.
HofmannCA, LotanRM, KuWW, OeltmannTN.Insulin-ricin B hybrid molecules mediate an insulin-associated effect on cells which do not bind insulin. J Biol Chem1983;258:11774–9.
33.
MillerDS.Stimulation of RNA and protein synthesis by intracel-lular insulin. Science1988;240:506–9.
34.
JochenAL, BerhanuP.Insulin-stimulated glucose transport and insulin internalization share a common postbinding step in adipocytes. Diabetes1987;36:542–5.
35.
KayalarC, WongWT.Metalloendoprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme. J Biol Chem1989;264:8928–34.
36.
KayalarC, WongWT, HendricksonL.Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors. J Cell Biochem1990;44:137–51.
37.
PeavyD, AbramJ, FrankB, DuckworthW.In vitro activity of biosynthetic human proinsulin: receptor binding and biological potency of proinsulin and insulin in isolated rat adipocytes. Diabetes1984;33:1062–7.
38.
PeavyDE, BrunnerMR, DuckworthWC, HookerCS, FrankBH.Receptor binding and biological potency of several split forms (conver-sion intermediates) of human proinsulin: studies in cultured IM-9 lym-phocytes and in vitro in rats. J Biol Chem1985;260:13989–94.
39.
SmithRM, JarettL.Partial characterization of mechanism of insulin accumulation in H35 hepatoma cell nuclei. Diabetes1990;39:683–9.
40.
SolerAP, ThompsonKA, SmithRM, JarettL.Immunological demonstration of the accumulation of insulin, but not insulin receptors, in nuclei of insulin-treated cells. Proc Natl Acad Sci USA1989;86:6640–4.
41.
DingL, BeckerAB, AkinoriS, RothRA.Comparison of the enzymatic and biochemical properties of human insulin-degrading enzyme and Escherichia coli protease III. J Biol Chem1992;267:2414–20.
42.
GarciaJV, FentonBW, RosnerMR.Isolation and characterization of an insulin-degrading enzyme from Drosophila melanogaster. Biochemistry1988;27:4237–44.
43.
KoleH, SmithD, LenardJ.Characterization and partial purifica-tion of an insulinase from neurospora crassa. Arch Biochem Biophys1992;297:199–204.
44.
FujitaA, OkaC, ArikawaY, KatagalT, TonouchiA, KuharaS, MisumiY.A yeast gene necessary for bud-site selection encodes a pro-tein similar to insulin-degrading enzymes. Nature1994;372:567–70.
45.
DuckworthWC, GarciaJV, LiepnieksJJ, HamelFG, HermodsonMA, FrankBH, RosnerMR.Drosophila insulin-degrading enzyme and rat skeletal muscle insulin protease cleave insulin at similar sites. Biochemistry1989;28:2471–7.
46.
RawlingsND, BarrettAJ.Evolutionary families of peptidases. Biochem J1993;290:205–18.
47.
HariJ, ShiiK, RothRA.In vivo association of 1251 insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-link-ing and immunoprecipitation with a monoclonal antibody. Endocrinology1987;120:829–31.
48.
HaradaS, SmithR, SmithJ, JarettL.Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway. Endocrinology1993;132:2293–8.
49.
BennettR, HamelF, DuckworthW.Identification and isolation of a cytosolic proteolytic complex containing insulin-degrading enzyme and the multicatalytic proteinase. Biochem Biophys Res Commun1994;202:1047–53.
BarrettE, JahnL, OliverasE, FryburgD.Chloroquine does not exert insulin-like actions on human forearm muscle metabolism. Am J Physiol1995;268:E820–4.
52.
DuckworthW, BennettR, HamelF.A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase. J Biol Chem1994;269:24575–80.
53.
BennettRG, HamelFG, DuckworthWC.Characterization of the peptidolytic activities of the insulin-degrading enzyme-proteasome com-plex. Diabetes1997;46:197–203.
54.
KupferSR, MarschkeKB, WilsonEM, FrenchFS.Receptor accessory factor enhances specific DNA binding of androgen and gluco-corticoid receptors. J Biol Chem1993;268:17519–27.
55.
KupferSR, WilsonEM, FrenchFS.Androgen and glucocorti-coid receptors interact with insulin-degrading enzyme. J Biol Chem1994;269:20622–8.
56.
BennettRG, HamelFG, DuckworthWC.Insulin inhibition of fatty acid α-oxidation in isolated peroxisomes. Diabetes1996;45:310A.
57.
GehmBD, RosnerMR.Regulation of insulin, epidermal growth factor, and transforming growth factor-α levels by growth factor-degrad-ing enzymes. Endocrinology1991;128:1603–9.
58.
MullerD, BaumeisterH, BuckeF, RichterD.Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme. Eur J Biochem1991;202:285–92.
59.
RothRA, MesirowML, YokonoK, BabaS.Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme. Endocr Res1984;10(2):101–12.
60.
ThompsonK, DeckerS, RosnerM.Identification of a novel receptor in Drosophila for both epidermal growth factor and insulin. Proc Natl Acad Sci USA1985;82:8443–7.
61.
StoppelliMP, GarciaJV, DeckerSJ, RosnerMR.Developmental regulation of an insulin-degrading enzyme from Drosophila melanogaster. Proc Natl Acad Sci USA1988;85:3469–73.
62.
KuoW, MontagA, RosnerM.Insulin-degrading enzyme is dif-ferentially expressed and developmentally regulated in various rat tis-sues. Endocrinology1993;132:604–11.
63.
KuehnL, DahlmannB, KoppF.Effect of the multicatalytic pro-teinase (prosome) on translational activity in rabbit reticulocyte lysates. FEBS Lett1990;261:274–8.
64.
DrazninB.Insulin signaling network—waiting for Copernicus [editorial]. Endocrinology1996;137:2647–8.
